Dr. Roger Nolan is a seasoned life sciences professional with experience in academic research, biotech start-ups, and drug and device development. He is a biochemist/pharmacologist by training with specific areas of expertise in diabetes, oncology, anti-infectives, and cardiovascular indications. He has co-founded and consulted with start-up and early-stage biotech companies, many of them supported by grant funding, to support their product development. Specifically, he has directed management of preclinical and clinical drug development programs, regulatory strategy and interactions, financing (both dilutive and non-dilutive), business development, and outsourcing to specialist service providers. Prior to a career in the biotech arena, Dr. Nolan held the position of Assistant Professor, Biochemistry and Internal Medicine, Eastern Virginia Medical School where he directed a research laboratory funded by grants and lectured to medical and graduate students in biochemistry. He also completed postdoctoral fellowships at the National Institute of Environmental Health Sciences and Burroughs Wellcome. When not working on early-stage biotech programs, Dr. Nolan enjoys golf, gardening, and woodwork.
Education: B.Sc. (Hons.) in Biochemistry from LaTrobe University, Australia; Ph.D. in Biochemistry/Pharmacology from Melbourne University.